News GSK cements Blenrep comeback with MHRA approval GSK's Blenrep has nearly completed its winding road as the multiple myeloma drug receives approval for second-line us in the UK.
News GSK reprimanded over "shocking error" in Omjjara info A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA.
News There's good news for RSV jab firms at delayed ACIP meeting GSK and Pfizer could see a resurgence in sales of their RSV vaccines if new recommendations at a CDC expert meeting are confirmed by agency leaders.
News GSK makes fresh neuroscience foray with £2bn+ ABL deal Neuroscience isn't listed as one of the top R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting.
News GSK ends decades-long hiatus in oral antibiotics for UTIs The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.
News GSK taps into UK health data for dementia study GSK joins with two UK research organisations to explore a possible link between its shingles vaccine Shingrix and a reduced risk of dementia.
News GSK cements Blenrep comeback with MHRA approval GSK's Blenrep has nearly completed its winding road as the multiple myeloma drug receives approval for second-line us in the UK.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
